• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生长分化因子 15 与中等射血分数和射血分数保留的慢性心力衰竭的临床特征的关系,取决于心肌梗死病史。

Growth differentiation factor 15 associations with clinical features of chronic heart failure with midrange ejection fraction and preserved ejection fraction depending on the history of myocardial infarction.

机构信息

Research Institute for Cardiology, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.

出版信息

Kardiologiia. 2021 May 31;61(5):59-64. doi: 10.18087/cardio.2021.5.n1449.

DOI:10.18087/cardio.2021.5.n1449
PMID:34112076
Abstract

Aim    To analyze associations between levels of the inflammatory marker, growth differentiation factor 15 (GDF-15), and echocardiographic indexes in CHF patients with mid-range and preserved left ventricular ejection fraction (LV EF) depending on the history of myocardial infarction (MI).Material and methods    This study included 34 CHF patients with preserved and mid-range LV EF after MI (group 1, n=19) and without a history of MI (group 2, n=15). Serum concentration of GDF-15 was measured with enzyme immunoassay (BioVendor, Czech Republic). Statistical analysis was performed with STATISTICA 10.0.Results    Patients of the study groups were age-matched [62 (58;67) and 64 (60;70) years, p=0.2] but differed in the gender; group 1 consisted of men only (100 %) whereas in group 2, the proportion of men was 53.3 % (p=0.001). Median concentration of GDF-15 was 2385 (2274; 2632.5) and 1997 (1534;2691) pg/ml in groups 1 and 2, respectively (p=0.09). Patients without MI showed a moderate negative correlation between LV EF and GDF-15 concentration (r= - 0.51, p=0.050) and a pronounced correlation between GDF-15 and LV stroke volume (r= -0.722, p=0.002). For patients after MI, a correlation between the level of GDF-15 and the degree of systolic dysfunction was not found (р>0.05).Conclusion    Blood concentration of the inflammatory marker, GDF-15, correlates with LV EF and stroke volume in CHF patients with preserved or mid-range LV EF and without a history of MI while no such correlations were observed for patients with a history of MI.

摘要

目的 分析炎症标志物生长分化因子 15(GDF-15)水平与中范围和保留左心室射血分数(LV EF)的 CHF 患者的超声心动图指标之间的关联,并根据心肌梗死(MI)史进行分组。

材料与方法 本研究纳入了 34 例 MI 后保留和中范围 LV EF 的 CHF 患者(组 1,n=19)和无 MI 史的患者(组 2,n=15)。采用酶联免疫吸附法(BioVendor,捷克共和国)测定血清 GDF-15 浓度。采用 STATISTICA 10.0 进行统计学分析。

结果 研究组患者年龄匹配[62(58;67)和 64(60;70)岁,p=0.2],但性别不同;组 1 仅为男性(100%),而组 2 中男性比例为 53.3%(p=0.001)。组 1 和组 2 的 GDF-15 浓度中位数分别为 2385(2274;2632.5)和 1997(1534;2691)pg/ml(p=0.09)。无 MI 的患者的 LV EF 与 GDF-15 浓度之间呈中度负相关(r= -0.51,p=0.050),GDF-15 与 LV 每搏量之间呈显著相关(r= -0.722,p=0.002)。对于 MI 后患者,未发现 GDF-15 水平与收缩功能障碍程度之间存在相关性(p>0.05)。

结论 在无 MI 史的保留或中范围 LV EF 的 CHF 患者中,炎症标志物 GDF-15 的血浓度与 LV EF 和每搏量相关,而在有 MI 史的患者中则无相关性。

相似文献

1
Growth differentiation factor 15 associations with clinical features of chronic heart failure with midrange ejection fraction and preserved ejection fraction depending on the history of myocardial infarction.生长分化因子 15 与中等射血分数和射血分数保留的慢性心力衰竭的临床特征的关系,取决于心肌梗死病史。
Kardiologiia. 2021 May 31;61(5):59-64. doi: 10.18087/cardio.2021.5.n1449.
2
[Diagnostic Value of Biochemical Markers in Patients With Chronic Heart Failure With Reduced, Borderline and Preserved Left Ventricular Ejection Fraction].[生化标志物在左心室射血分数降低、临界和保留的慢性心力衰竭患者中的诊断价值]
Kardiologiia. 2017 Mar;57(3):39-45.
3
Growth differentiation factor-15 is a useful prognostic marker in patients with heart failure with preserved ejection fraction.生长分化因子 15 是射血分数保留的心力衰竭患者有用的预后标志物。
Can J Cardiol. 2014 Mar;30(3):338-44. doi: 10.1016/j.cjca.2013.12.010. Epub 2013 Dec 18.
4
Growth-differentiation factor-15 and major cardiac events.生长分化因子 15 与主要心脏不良事件。
Am J Med Sci. 2014 Apr;347(4):305-11. doi: 10.1097/MAJ.0b013e318291cd4e.
5
The level of growth differentiation factor 15 as a predictor of left atrial thrombosis in patients with nonvalvular atrial fibrillation.生长分化因子 15 水平作为非瓣膜性心房颤动患者左心房血栓形成的预测因子。
Kardiologiia. 2021 Jul 31;61(7):44-54. doi: 10.18087/cardio.2021.7.n1588.
6
The partnership between renalase and ejection fraction as a risk factor for increased cardiac remodeling biomarkers in chronic heart failure patients.肾酶与射血分数作为慢性心力衰竭患者心脏重构生物标志物风险因素的相关性。
Curr Med Res Opin. 2020 Jun;36(6):909-919. doi: 10.1080/03007995.2020.1756233. Epub 2020 Apr 29.
7
[Clinical and laboratory associations of liver fibrosis indexes in patients with decompensated Chronic Heart Failure II-IV Functional Classes].失代偿性慢性心力衰竭II-IV功能分级患者肝纤维化指标的临床及实验室关联
Kardiologiia. 2020 Jun 3;60(5):920. doi: 10.18087/cardio.2020.5.n920.
8
Left ventricular volume and ejection fraction response to exercise in chronic congestive heart failure: difference between dilated cardiomyopathy and previous myocardial infarction.慢性充血性心力衰竭患者运动时左心室容积和射血分数的反应:扩张型心肌病与既往心肌梗死之间的差异
Am J Cardiol. 1985 Apr 1;55(8):1027-31. doi: 10.1016/0002-9149(85)90740-4.
9
Growth Differentiation Factor-15 as a Predictor of Functional Capacity, Frailty, and Ventricular Dysfunction in Patients With Aortic Stenosis and Preserved Left Ventricular Ejection Fraction.生长分化因子 15 作为左心室射血分数保留的主动脉瓣狭窄患者心功能能力、虚弱和心室功能障碍的预测因子。
Am J Cardiol. 2023 Jan 1;186:11-16. doi: 10.1016/j.amjcard.2022.09.029. Epub 2022 Nov 3.
10
Prediction of heart failure post myocardial infarction: comparison of ejection fraction, transmitral filling parameters, and the index of myocardial performance.心肌梗死后心力衰竭的预测:射血分数、二尖瓣充盈参数及心肌性能指数的比较
Echocardiography. 2003 Nov;20(8):691-701. doi: 10.1111/j.0742-2822.2003.02156.x.

引用本文的文献

1
Angiotensin-Converting Enzyme Inhibitor Therapy Effects in Patients With Heart Failure With Preserved and Mid-Range Ejection Fraction.血管紧张素转换酶抑制剂治疗对射血分数保留和中度降低的心力衰竭患者的影响
Cardiol Res. 2021 Dec;12(6):363-368. doi: 10.14740/cr1322. Epub 2021 Nov 5.